Gladstone Home blank GIVI HOME
 
spacer
 
Supporting Gladstone
Publications 2004-2005
  • Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams SA, Greene WC. Nef is physically recruited into the immunological synapse and potentiates T-cell activation early after TCR engagement. J. Immunol. 175:6050–6057, 2005.
  • Kwon H, Ogle L, Benitez B, Bohuslav J, Montano M, Felsher DW, Greene WC. Lethal cutaneous disease in transgenic mice conditionally expressing HTLV-I Tax. J. Biol. Chem. 280:35713–35722, 2005.
  • Chen L-f, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder LM, Greene WC. NF-kB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25:7966–7975, 2005.
  • Chen L-f, Greene WC. Assessing Acetylation of NF-kB. Methods 36:368–375, 2005.
  • Williams SAF, Greene WC. Host factors regulating post-integration latency of HIV. Trends Microbiol. 13:137–139, 2005.
  • Keppler OT, Allespach I, Schüller L, Fenard D, Greene WC, Fackler OT. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 79:1655–1665, 2005.
  • Stopak K, Greene WC. Protecting APOBEC3G: A potential new target for HIV drug discovery. Curr. Opin. Invest. Drugs. 6:141–147, 2005.
  • Yonezawa A, Cavrois M, Greene WC. Studies of Ebola virus glycoprotein-mediated entry and fusion using pseudotyped HIV-1 virions: involvement of cytoskeletal proteins and enhancemant by tumor necrosis factor α. J. Virol.79:918–926, 2005.
  • Kreisberg JF, Doitsh G, Greene WC. Mechanisms of HIV-infected versus uninfected T-cell killing. In: Cell Death During HIV Infection (Badley AD, ed), CRC Press, Boca Raton, FL, pp. 207–228, 2005.
  • Williams SA, Chen L-F, Kwon H, Fenard D, Bisgrove D, Verdin E, Greene WC. Prostratin antagonizes HIV latency by activating NF-kB. J. Biol. Chem. 279:42008–42017, 2004.
  • Greene WC. Redistricting the retroviral restriction factors. Nat. Med. 10:778–780, 2004.
  • Cavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC. HIV-1 virion fusion assay: uncoating not required and no effect of nef on fusion. Virology. 328:36–44, 2004.
  • Greene WC. The brightening future of HIV therapeutics. Nat. Immunol. 5:867–871, 2004.
  • Bohuslav J, Chen L-F, Kwon H, Mu Y, Greene WC. p53 induces NF-kB activation by an IkB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279:26115–26125, 2004.
  • Greene WC, Chen L-f. Regulation of NF-kB action by reversible acetylation. In: Reversible Protein Acetylation: Novartis Foundation Symposium No. 259, John Wiley & Sons Ltd., Chichester, UK. 208–222, 2004.
  • Chen L-F, Greene WC. Shaping the nuclear action of NF-kB. Nat. Rev. Mol. Cell Biol. 5:392-401, 2004.
  • O'Mahony A, Montano M, Van Beneden K, Chen L-f, Greene WC. Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-kB requires IkB kinase-1-mediated phosphorylation of RelA/p65. J. Biol. Chem. 279:18137-18145, 2004.
  • Cavrois M, Neidleman J, Bigos M, Greene WC. Fluorescence resonance energy-based HIV-1 virion fusion assay. In: Flow Cytometry Protocols (Hawley TS, Hawley RG, eds), Humana Press, Totowa, NJ, pp. 333-343, 2004.
  • Greene, WC. How resting T cells deMURR HIV infection. Nat. Immunol. 5:18–19, 2004.
  • Schaeffer E, Soros VB, Greene WC. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J. Virol. 78:1375–1383, 2004.

Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF